Sam Altman's longevity company is testing an extra-strength Alzheimer's drug after disappointing trial results
Business Insider · LC · trust 46/100
The Sam Altman-backed longevity biotech company is upping the dose of its experimental Alzheimer's drug in clinical trials.
Read the original at Business Insider →
Open in TruthVane →